BMRN
BioMarin Pharmaceutical Inc (BMRN) Sec Form 10K
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Sec Form 10K
BioMarin Pharmaceutical Inc (BMRN) U.S. Food and Drug Administration Approves BioMarin’s PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) FY 2026 Other Release
BioMarin Pharmaceutical Inc (BMRN) Sec Form 8K
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Sec Form 8K
BioMarin Pharmaceutical Inc (BMRN) Summit Meeting
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Summit Meeting
BioMarin Pharmaceutical Inc (BMRN) Barclays 28th Annual Global Healthcare Conference
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) FY 2026 Corporate Conference
BioMarin Pharmaceutical Inc (BMRN) Leerink 2026 Global Healthcare Conference
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) FY 2026 Corporate Conference
BioMarin Pharmaceutical Inc (BMRN) TD Cowen 46th Annual Health Care Conference
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) FY 2026 Corporate Conference
BioMarin Pharmaceutical Inc (BMRN) Q4 2025 Earnings Results
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Q4 2025 Earnings Release
BioMarin Pharmaceutical Inc (BMRN) Q4 2025 Earnings Call
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Q4 2025 Earnings Conference
BioMarin Pharmaceutical Inc (BMRN) Sec Form 8K
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Sec Form 8K